Correlation Between TAKEDA and 90331HPL1

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both TAKEDA and 90331HPL1 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining TAKEDA and 90331HPL1 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between TAKEDA PHARMACEUTICAL LTD and US BANK NATIONAL, you can compare the effects of market volatilities on TAKEDA and 90331HPL1 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in TAKEDA with a short position of 90331HPL1. Check out your portfolio center. Please also check ongoing floating volatility patterns of TAKEDA and 90331HPL1.

Diversification Opportunities for TAKEDA and 90331HPL1

0.53
  Correlation Coefficient

Very weak diversification

The 3 months correlation between TAKEDA and 90331HPL1 is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding TAKEDA PHARMACEUTICAL LTD and US BANK NATIONAL in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on US BANK NATIONAL and TAKEDA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on TAKEDA PHARMACEUTICAL LTD are associated (or correlated) with 90331HPL1. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of US BANK NATIONAL has no effect on the direction of TAKEDA i.e., TAKEDA and 90331HPL1 go up and down completely randomly.

Pair Corralation between TAKEDA and 90331HPL1

Assuming the 90 days trading horizon TAKEDA PHARMACEUTICAL LTD is expected to under-perform the 90331HPL1. But the bond apears to be less risky and, when comparing its historical volatility, TAKEDA PHARMACEUTICAL LTD is 1.34 times less risky than 90331HPL1. The bond trades about -0.33 of its potential returns per unit of risk. The US BANK NATIONAL is currently generating about -0.2 of returns per unit of risk over similar time horizon. If you would invest  9,948  in US BANK NATIONAL on August 31, 2024 and sell it today you would lose (401.00) from holding US BANK NATIONAL or give up 4.03% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy75.0%
ValuesDaily Returns

TAKEDA PHARMACEUTICAL LTD  vs.  US BANK NATIONAL

 Performance 
       Timeline  
TAKEDA PHARMACEUTICAL LTD 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days TAKEDA PHARMACEUTICAL LTD has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Bond's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for TAKEDA PHARMACEUTICAL LTD investors.
US BANK NATIONAL 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days US BANK NATIONAL has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, 90331HPL1 is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

TAKEDA and 90331HPL1 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with TAKEDA and 90331HPL1

The main advantage of trading using opposite TAKEDA and 90331HPL1 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if TAKEDA position performs unexpectedly, 90331HPL1 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 90331HPL1 will offset losses from the drop in 90331HPL1's long position.
The idea behind TAKEDA PHARMACEUTICAL LTD and US BANK NATIONAL pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
CEOs Directory
Screen CEOs from public companies around the world
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Commodity Directory
Find actively traded commodities issued by global exchanges
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance